Relay Therapeutics, Inc.

NASDAQ:RLAY

3 (USD) • At close May 9, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 7.67900010.007-0.00125.2020.1190.2260.2530.3440.3650.4190.5670.6660.8440.95282.6540000000
Kosten van de omzet 07.24401.3681.3951.3751.3631.3341.1971.1661.03360.5110.9751.03444.15545.14730.62267.73924.37621.66621.70000
Brutowinst 7.679-7.2440-1.3688.612-1.37623.839-1.215-0.971-0.913-0.689-60.146-0.556-0.467-43.489-44.303-29.6714.915-24.376-21.666-21.70000
Brutowinstmarge 10000.8611,3760.946-10.21-4.296-3.609-2.003-164.784-1.327-0.824-65.299-52.492-31.1660.180000000
Onderzoek- en ontwikkelingskosten 73.80968.07576.61991.99282.40377.49681.49488.20182.82767.27766.960.51151.66751.90744.97445.14730.62232.12324.37621.66621.722.40718.25616.39713.335
Algemene en administratieve kosten 18.73916.90419.7520.13919.79916.76618.48520.1219.57916.37116.07417.46516.06815.54714.68214.42212.73515.54312.2316.0534.7583.4263.6523.5083.067
Verkoop- en marketingkosten 000-1.368-1.39500000000000000000000
Verkoop-, algemene en administratieve kosten 18.73916.90419.7518.77118.40416.76618.48520.1219.57916.37116.07417.46516.06815.54714.68214.42212.73515.54312.2316.0534.7583.4263.6523.5083.067
Overige kosten 000-0.0020.0250.001-0.002-0.014-0.003-0.0240.0070.018-0.021020.001-0.005-0.008-0.005-0.00300-0.0010-0.057
Bedrijfskosten 92.54884.97996.369110.763100.80794.26299.979108.321102.40683.64882.97477.97667.73567.45459.65659.56943.35747.66636.60727.71926.45825.83321.90819.90516.402
Bedrijfsresultaat -84.869-84.979-96.369-112.131-92.195-92.196-73.577-106.05-101.177-72.851-85.892-77.811-62.721-67.456-60.99-193.58-42.40534.988-36.607-27.719-26.458-25.833-21.908-19.905-16.402
Bedrijfsresultaat ratio -11.052000-9.21392,196-2.919-891.176-447.686-287.949-249.686-213.181-149.692-118.97-91.577-229.36-44.5430.4230000000
Totaal overige inkomsten en kosten netto 7.8048.9758.2648.5458.9768.7017.8437.5456.9385.3481.721.0230.6750.2670.1570.1810.2210.2880.5290.9951.5721.922.2352.3682.22
Inkomen voor belasting -77.065-76.004-88.105-92.212-81.387-83.495-65.734-98.505-94.239-67.503-84.172-76.788-62.046-67.456-60.833-193.399-42.18435.276-36.078-26.724-24.886-23.913-19.673-17.537-14.182
Inkomen voor belasting ratio -10.036000-8.13383,495-2.608-827.773-416.987-266.81-244.686-210.378-148.081-118.97-91.341-229.146-44.3110.4270000000
Belastingkosten 00001.35218.012-1.363-9.711-6.938-24.1883.091-0.805-10.561-0.8360.1570.1810.2210.2880.5290.9951.5721.922.2352.3682.22
Nettowinst -77.065-76.004-88.105-92.212-81.387-83.495-65.734-98.505-87.301-43.315-87.263-76.788-51.485-67.456-60.833-193.399-42.18435.276-36.078-26.724-24.886-23.913-19.673-17.537-14.182
Nettowinstmarge -10.036000-8.13383,495-2.608-827.773-386.288-171.206-253.672-210.378-122.876-118.97-91.341-229.146-44.3110.4270000000
WPA (Winst Per Aandeel) -0.46-0.45-0.63-0.69-0.62-0.68-0.54-0.81-0.72-0.36-0.79-0.71-0.48-0.66-0.66-2.1-0.470.5-0.51-6.06-5.99-6.24-5.53-5.28-4.59
Verwaterde WPA -0.46-0.45-0.63-0.69-0.62-0.68-0.54-0.81-0.72-0.36-0.79-0.71-0.48-0.66-0.66-2.1-0.470.5-0.51-6.06-5.99-6.24-5.53-5.28-4.59
EBITDA -84.869-81.486-95.002-110.763-90.8-92.888-73.414-106.868-100.983-82.229-81.597-76.655-66.341-66.422-57.978-57.765-41.48636.188-35.694-26.854-25.599-24.98-21.274-19.214-15.735
EBITDA ratio -11.052000-9.07492,888-2.913-898.05-446.827-325.016-237.201-210.014-158.332-117.146-87.054-68.442-43.5780.4380000000